Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Post by inviolablspiriton Nov 21, 2024 6:06pm
78 Views
Post# 36324888

News Releases

News ReleasesI'm going to guess that we may not get the agreement signed and announced until after the financials are released.   And we may get other news releases from now until then.   Or we get the agreement signed before the financials and then we see other news releases after the financials.  Either way I predict we have news release(s) coming before financials are released in December.  

I'm also interested in news releases regarding European countries.  Last time I emailed Nick he said "the regulations for Europe are complex, but not impossible".  And if there's anyone that understands regulations and can get a deal done, it's Nick.  So I think anything out of Europe will take more time then anything we see signed in North America.   When Nick is back in Europe that's when we may see deals being signed.  Anything I see signed from Europe before that, I'll view as a bonus.  

Also depending on what deals are being signed, some deals may require the other party's desire to see the audited Y/E financial statements first before going forward.  
<< Previous
Bullboard Posts
Next >>